Hill-Rom Holdings, Inc. HRC
Apr 24, 2025, 3:47 PM EDT
52-week range unavailable
- Market cap
- 10.30B
- Revenue (ttm)
- 3.02B
- Profit margin
- 8.23%
- Shares out
- 66.05M
- Forward P/E
- 21.66
- Dividend
- 0.96 (0.62%)
- Ex-dividend date
- Dec 13, 2021
- Volume
- 566.40K
- Open
- 155.89
- Previous close
- 155.96
- Day's range
- 155.86 – 155.99
- Beta
- 0.55
- Analysts
- Hold
- Price target
- 156.00 (+0.0%)
- Earnings date
- Feb 4, 2022
Key statistics
- Enterprise value
- 12.19B
- PEG ratio
- 2.91
- Price / sales
- 3.41
- Price / book
- 5.47
- Dividend yield
- 0.62%
- Payout ratio
- 25.27%
- Revenue growth
- 13.10%
- Free cash flow
- 394.39M
- Total cash
- 271.80M
- Total debt
- 2.16B
- Return on equity
- 13.78%
- Short % of float
- 12.84%
- 50-day average
- 154.34
- 200-day average
- 130.22
Analyst view
Consensus: hold
- Strong buy3
- Buy4
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 4, 2022
Expected Feb 4, 2022. Consensus EPS estimate 1.45.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2022 | Dec 1, 2021 | 1.45 | — | — | — |
| Nov 5, 2021 | Sep 1, 2021 | 1.47 | — | — | — |
| Jul 30, 2021 | Jun 1, 2021 | 1.34 | — | — | — |
| Apr 30, 2021 | Mar 1, 2021 | 1.43 | — | — | — |
| Feb 5, 2021 | Dec 1, 2020 | 1.05 | — | — | — |
| Nov 6, 2020 | Sep 1, 2020 | 1.08 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 20, 2021 | Morgan Stanley | down | Overweight | Equal-Weight |
| Sep 8, 2021 | Keybanc | down | Overweight | Sector Weight |
| Sep 3, 2021 | Baird | down | Outperform | Neutral |
| Aug 10, 2021 | B of A Securities | down | Buy | Neutral |
| Aug 2, 2021 | Morgan Stanley | main | — | Overweight |
| Aug 2, 2021 | Baird | main | — | Outperform |
About Hill-Rom Holdings, Inc.
Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. The company operates through Patient Support Systems, Front Line Care, and Surgical Solutions segments. It offers medical surgical beds, intensive care unit beds, and bariatric patient beds, patient mobility solutions, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. The company also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising non-invasive devices that provide respiratory support and assist patients in the mobilization of retained blockages. In addition, it offers surgical solutions that include tables, lights, and pendants; and positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, the company sells and rents products to acute and extended care facilities through direct sales force and distributors; sells and rents products directly to patients in the home; and sells products to primary care facilities through distributors. Hill-Rom Holdings, Inc. was founded in 1915 and is headquartered in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- hillrom.com
News
Earnings Scheduled For July 30, 2021
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Monday
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Wednesday
Earnings Scheduled For July 31, 2020
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday
Your note
Sign in to keep a note on HRC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BODEM BARBARA W | Chief Financial Officer | Conversion of Exercise of derivative security | Dec 3, 2020 | 6,352 |
| DEMPSEY WILLIAM G | Director | Conversion of Exercise of derivative security | Jul 15, 2019 | 5,376 |
| DODRILL AMY M | Officer | Conversion of Exercise of derivative security | Nov 8, 2020 | 2,636 |
| FRANK ANDREAS G | Officer | Conversion of Exercise of derivative security | Dec 3, 2020 | 16,770 |
| GROETELAARS JOHN P | Chief Executive Officer | Conversion of Exercise of derivative security | May 16, 2021 | 25,075 |
| JOHNSON PAUL SHERWOOD | Officer | Sale | Apr 7, 2021 | 6,221 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group, Inc. (The) | 9.84% | 6,496,298 | 974.44M | Sep 29, 2021 |
| Blackrock Inc. | 8.95% | 5,911,980 | 886.80M | Sep 29, 2021 |
| Victory Capital Management Inc. | 3.76% | 2,485,501 | 372.83M | Sep 29, 2021 |
| Wellington Management Group, LLP | 3.33% | 2,201,343 | 330.20M | Sep 29, 2021 |
| Pentwater Capital Management Lp | 2.80% | 1,850,000 | 277.50M | Sep 29, 2021 |
| State Street Corporation | 2.64% | 1,741,587 | 261.24M | Sep 29, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Hartford Mid Cap Fund | 3.33% | 2,197,767 | 304.30M | Jul 30, 2021 |
| Victory Portfolios-Sycamore Established Value Fund | 3.05% | 2,012,000 | 278.58M | Jul 30, 2021 |
| Vanguard Total Stock Market Index Fund | 2.82% | 1,863,674 | 279.55M | Sep 29, 2021 |
| iShares Core S&P Midcap ETF | 2.68% | 1,767,546 | 265.13M | Sep 29, 2021 |
| Vanguard Small-Cap Index Fund | 2.49% | 1,641,777 | 246.27M | Sep 29, 2021 |
| Vanguard Extended Market Index Fund | 1.35% | 889,078 | 133.36M | Sep 29, 2021 |
